Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO
December 14, 2020 07:00 ET
|
Ergomed plc
PRESS RELEASE Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO Further expansion of Ergomed’s presence in the strategically important US market MedSource’s...
Ergomed to Present at Jefferies Virtual 2020 Healthcare Conference
May 28, 2020 07:00 ET
|
Ergomed plc
PRESS RELEASE Ergomed to Present at Jefferies Virtual 2020 Healthcare Conference Guildford, UK – 28 May 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing...
Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development Programme
April 06, 2020 07:00 ET
|
Ergomed plc
PRESS RELEASE Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development Programme Guildford, UK – 6 April 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the...
Ergomed’s PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial Program
March 30, 2020 07:00 ET
|
Ergomed plc
PRESS RELEASE Ergomed’s PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial Program Guildford, UK – 30 March 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the...